Sgmo stock price analysts modeling sgmo stock price

Analysts modeling sgmo stock price scenarios for 2024 earnings suggest that milestone payments from existing collaborations could provide unexpected upside. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. One other stock from the same industry, Armata Pharmaceuticals, Inc. (ARMP), is yet to report results for the quarter ended March 2025. Observers note that sgmo stock price could react sharply to any FDA fast-track designation for its neurological therapies, a sector that’s attracting strong investor interest this summer.